Nkarta (NASDAQ:ANNX) Insider Buys $11,900,000.00 in Stock

Nkarta (NASDAQ:ANNX) insider James E. Flynn purchased 700,000 shares of Nkarta stock in a transaction on Tuesday, July 28th. The shares were purchased at an average cost of $17.00 per share, with a total value of $11,900,000.00.

NASDAQ:ANNX opened at $18.54 on Friday. Nkarta has a twelve month low of $15.33 and a twelve month high of $19.00.

Nkarta Company Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration.

Featured Article: How big is the FinTech market?

Receive News & Ratings for Nkarta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nkarta and related companies with MarketBeat.com's FREE daily email newsletter.